Constipation Clinical Trial
Official title:
Chinese Herbal Medicine for Functional Constipation: A Randomized, Double-blind, Placebo Controlled Trial
Functional constipation (FC) is a common complaint in clinical practice, but treatment for this condition in conventional medicine is suboptimal. Complementary and alternative medicines, especially Chinese herbal medicine (CHM) are used frequently by patients, however, there is little research evidence about these commonly used CHM. The purpose of the study is evaluate the efficacy and safety of an ancient CHM formula, MaZiRenWan (MZRW), by comparing with placebo.
Constipation is a common gastrointestinal complaint in clinical practice, which affects in
estimated 12%-19% of American, 14% of Asian, and up to 27% of the population depending on
demographic factor, sampling, and definition. With the unsatisfactory response to current
symptomatic treatments, many patients seek help from traditional Chinese medicine (TCM),
mostly by taking Chinese herbal medicine (CHM).
According to the TCM theory, constipation can be broadly divided into two types, excessive
and deficient, based on the underlying aetiology. The former is characterized by the
presence of Heat or pathological accumulation of Qi. Heat causes constipation by drying the
Intestines and the stool. Patients present with hard, dry, pellet like stool, red
complexion, dry mouth or halitosis, red tongue with a dry yellow coat, and slippery and
rapid pulse. Qi stagnation causes constipation by disrupting the normal movement and descent
of Stomach and Intestinal Qi. Patients present difficulty in passing stools, feelings of
incomplete evacuation, abdominal distension or pain, frequent belching and flatulence,
tongue with thin coat and wiry pulse. The latter, deficient constipation, is delineated as
the dryness from insufficient fluid lubrication in the form of blood or lack of propulsion
power from the deficiency of Qi or Yang. Besides, the treatment approaches vary from
syndrome to syndrome.
The formula of MaZiRenWan (MZRW) composed of six Chinese herbs is firstly recorded in a TCM
classic, Discussion of Cold-induced Disorders (Shang Han Lun), and it has been commonly used
for constipation in excessive pattern throughout Asia since the Han Dynasty (A.D. 200). By
combining the actions of these herbs, MZRW can moisten the Intestines, drain heat, promote
the movement of Qi and unblock the bowel. Although previous studies show that MZRW has
purgative and laxative effects and may be useful for functional constipation (FC), there are
significant methodological weaknesses. Furthermore, the dose of CHM intervention being
investigated from the first randomized controlled trial (RCT) published in 1983 is always
based on the practitioner's experience, TCM literatures, or experts' comments, but not the
results from stringent clinical trials, such as dose determination study. Therefore, the
evidence produced will be attenuated or even misleading if improper dose is taken.
In the present study, the efficacy and safety of MZRW in optimal dosage were justified by
comparing with placebo under strict clinical trial design.
;
Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator, Outcomes Assessor), Primary Purpose: Treatment
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT05517460 -
The Efficacy of Auricular Acupressure on Improving Constipation Among Residents in Community Rehabilitation Center
|
N/A | |
Recruiting |
NCT06292949 -
Clinical Study of Resistant Starch in Improving Constipation
|
N/A | |
Recruiting |
NCT04132661 -
MRI Assessment of Mode of Action of Bisacodyl, Single Dose
|
Phase 4 | |
Completed |
NCT02726295 -
The Efficacy of Mutaflor(E. Coli Nissle 1917, Mutaflor®) for Chronic Constipation:Multicenter Study
|
Phase 4 | |
Terminated |
NCT02839889 -
Tolerability, Safety, and Feasibility of Naloxegol in Patients With Cancer and OIC (Opioid Induced Constipation)
|
Phase 4 | |
Recruiting |
NCT02255747 -
Anal Dilatation for Infants and Children With Constipation
|
N/A | |
Completed |
NCT02246647 -
Biomarkers for Intestinal Permeability in Patients With Constipation
|
||
Completed |
NCT01566409 -
Maintenance Treatment for Children With Constipation
|
N/A | |
Completed |
NCT02863848 -
Effect of Inulin-type Fructans on Constipated Children.
|
N/A | |
Completed |
NCT01695915 -
Diurnal Variation in Rectal Diameter
|
N/A | |
Completed |
NCT01710579 -
Normal Values in Ano-rectal 3D High Resolution Manometry
|
N/A | |
Completed |
NCT02658201 -
Ultrafast MRI Imaging to Exclude Constipation
|
N/A | |
Completed |
NCT01438567 -
A Study to Demonstrate Improvement in Symptoms of Constipation in Subjects That Require Around-the-clock Opioid Pain Killer Therapy
|
Phase 3 | |
Completed |
NCT01474499 -
A Trial of Docusate Sodium and Sorbitol Rectal Solution for the in Patients With Constipation
|
Phase 3 | |
Completed |
NCT01411501 -
Efficacy and Safety of Acupuncture for Functional Constipation
|
Phase 3 | |
Completed |
NCT01170039 -
The Effectiveness of Lubiprostone in Constipated Diabetics
|
Phase 4 | |
Completed |
NCT00931853 -
Efficacy and Tolerability of Cassia Fistula Plus Senna Alexandrina Miller (Sugar Free) in the Chronic Functional Constipation (CFC).
|
Phase 3 | |
Active, not recruiting |
NCT02442115 -
Impact of Improving GI Symptoms on Autism Symptoms and Oxidative Stress
|
||
Terminated |
NCT01003249 -
Dysfunctional Voiding and Lower Urinary Tract Symptoms With Baclofen
|
Phase 4 | |
Completed |
NCT00994851 -
Evaluation of Cassia Fistula + Senna Alexandrina Miller in the Chronic Functional Constipation Treatment.
|
Phase 3 |